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Breast cancer is the leading cause of mortality among women with over a million cases recorded 
globally. Haptoglobin (Hp) is an acute phase glycoprotein whose major role is to remove free 
hemoglobin from circulation. The prevalence of Hp genotypes varies between populations from 
different countries and ethnic groups. Several studies have investigated the association of 
haptoglobin genotypes with breast cancer occurrence, but have reported conflicting results. 
However, only few studies have investigated the incidence of Hp genotypes, and their 
association to breast cancer occurrence and malaria in Nigeria. In this study, the association of 
haptoglobin genotypes, breast cancer and malaria was investigated among healthy women and 
clinically diagnosed breast cancer patients. Blood samples were collected from Lagos and Ogun 
States, and DNA was extracted using standard methods. Haptoglobin genotypes and malaria 
were detected by polymerase chain reaction (PCR) and agarose gel electrophoresis in breast 
cancer patients (n=75) and healthy controls (n=287). The percentage distribution of the 362 
women that participated in the study was as follows: Hp 2-1 (39.8%) genotype had the highest 
prevalence, followed by Hp 1-1 (34.5%), and Hp 2-2 (25.7%). A highly significant increase in 
Hp 1-1 genotype (P<0.05) was observed among patients in the BC group when compared with 
the control group. Furthermore, a higher frequency of Hp 1 allele (54.4%) than Hp 2 allele 
(45.6%) was observed from both groups. However, no significant difference was observed in Hp 
1 allele among the BC group when compared with the control group. A significant increase in 
Hp 1 allele (P<0.05) was observed among malaria-positive patients in the control group. An 
increase in Hp 1 allele was also observed in BC group, but it was not significant. The result of 
this study suggest an association between Hp 1-1 genotype and breast cancer occurrence, and an 
association between Hp 1 allele and increased risk of malaria infection. 
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